Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Champions Oncolog (NQ: CSBR )

4.850 -0.010 (-0.21%)
Streaming Delayed Price Updated: 9:38 AM EDT, Jul 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 711
Open 4.860
Bid (Size) 4.860 (1)
Ask (Size) 5.060 (1)
Prev. Close 4.860
Today's Range 4.850 - 4.860
52wk Range 4.500 - 7.320
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Performance

YTD
-16.23%
-16.23%
1 Month
+1.68%
+1.68%
3 Month
-4.34%
-4.34%
6 Month
-16.23%
-16.23%
1 Year
-22.89%
-22.89%

More News

Read More
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Via ACCESSWIRE
Champions Oncology: Q3 Earnings Insights
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $12.0 Million
Via ACCESSWIRE
Earnings Outlook For Champions Oncology
Via Benzinga
Recap: Champions Oncology Q2 Earnings
Via Benzinga
Earnings Outlook For Champions Oncology
Via Benzinga
Earnings Scheduled For March 12, 2024
Via Benzinga
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
Via ACCESSWIRE
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
Via ACCESSWIRE
Insiders Buying Solid Biosciences And 2 Other Stocks
Via Benzinga
Insiders Buying Tilly's And 2 Other Stocks
Via Benzinga
Why Is RiskOn International (ROI) Stock Up 28% Today?
Via InvestorPlace
CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Champions Oncology Reports Quarterly Revenue of $11.6 Million
Via ACCESSWIRE
Earnings Scheduled For December 12, 2023
Via Benzinga
Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023
Via ACCESSWIRE
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification
Via ACCESSWIRE
Champions Oncology Announces the Addition of Brady Davis as President
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $12.6 Million
Via ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023
Via ACCESSWIRE
Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.